GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.23−0.01 (-4.53%)
Close on Oct 19, 2026Market cap $1.04MP/E –Yield –
GeoVax Labs free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
GeoVax Labs's free cash flow for the twelve months ending Jun 30, 2026 was -$18.37M. For fiscal 2025 it was -$21.50M. The highest annual figure on record is -$315.52K in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.50M | – |
| FY2024 | Dec 31, 2024 | -$24.70M | – |
| FY2023 | Dec 31, 2023 | -$25.22M | – |
| FY2022 | Dec 31, 2022 | -$19.16M | – |
| FY2021 | Dec 31, 2021 | -$11.24M | – |
| FY2020 | Dec 31, 2020 | -$2.91M | – |
| FY2019 | Dec 31, 2019 | -$1.41M | – |
| FY2017 | Dec 31, 2017 | -$1.69M | – |
| FY2015 | Dec 31, 2015 | -$2.72M | – |
| FY2014 | Dec 31, 2014 | -$2.29M | – |
| FY2013 | Dec 31, 2013 | -$1.78M | – |
| FY2011 | Dec 31, 2011 | -$315.52K | – |
| FY2010 | Dec 31, 2010 | -$2.44M | – |
| FY2009 | Dec 31, 2009 | -$1.70M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.54M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.96M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.21M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.75M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.32M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.68M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.10M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.06M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.85M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.40M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.66M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.28M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.70M | – |
| Q3 FY2020 | Sep 30, 2020 | -$285.60K | – |
| Q4 FY2019 | Dec 31, 2019 | -$284.09K | – |
| Q3 FY2019 | Sep 30, 2019 | -$343.93K | – |
| Q2 FY2019 | Jun 30, 2019 | -$456.45K | – |
| Q1 FY2019 | Mar 31, 2019 | -$321.63K | – |
| Q4 FY2017 | Dec 31, 2017 | -$448.44K | – |
| Q3 FY2017 | Sep 30, 2017 | -$478.77K | – |
| Q2 FY2017 | Jun 30, 2017 | -$429.15K | – |
| Q1 FY2017 | Mar 31, 2017 | -$336.45K | – |
See a number that looks wrong?